Integration site analysis is becoming a critical tool in evaluating the safety of gene therapies, but how does it actually work, and when does it matter most? Michael Stump and Matteo Franco of ProtaGene break down the science, the risk, and the evolving role of CROs in this rapidly changing field.
Loading summary